Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany

Cai, Rui; Gerlier, Laetitia; Eichner, Martin; Schwehm, Markus; Rajaram, Sankarasubramanian; Mould-Quevedo, Joaquin; Lamotte, Mark

dc.contributor.author	Eichner, Martin
dc.date.accessioned	2022-01-10T09:41:46Z
dc.date.available	2022-01-10T09:41:46Z
dc.date.issued	2021
dc.identifier.issn	1941-837X
dc.identifier.uri	http://hdl.handle.net/10900/122761
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/13696998.2021.1908000	de_DE
dc.subject.ddc	610	de_DE
dc.title	Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_02250
utue.publikation.seiten	490-501	de_DE
utue.personen.roh	Cai, Rui
utue.personen.roh	Gerlier, Laetitia
utue.personen.roh	Eichner, Martin
utue.personen.roh	Schwehm, Markus
utue.personen.roh	Rajaram, Sankarasubramanian
utue.personen.roh	Mould-Quevedo, Joaquin
utue.personen.roh	Lamotte, Mark
dcterms.isPartOf.ZSTitelID	Journal of Medical Economics	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE